dockets: FDA-2026-P-10693
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-P-10693 | FDA | Requests that the FDA rescind their decision to file Zydus’s section 505(b)(2) applications for apparent duplicates of DESCOVY and VEMLIDY and refuse to grant either of Zydus’s products an A-rating reflecting a determination of therapeutic equivalence, should such a determination become relevant. | Nonrulemaking | 2026-09-15T13:52:03Z | 0b000064b951d330 | list_pull |
Links from other tables
- 91 rows from docket_id in documents